ElexoPharm GmbH
Im Stadtwald, Geb. A1
Saarbrücken
66123
Germany
Tel: 49-0-681-302-68320
Fax: 49-0-681-9102894
Website: http://www.elexopharm.de/
Email: info@elexopharm.de
About ElexoPharm GmbH
The ElexoPharm GmbH located in Saarbruecken is a Contract Research Organisation offering high quality research in the field of medicinal chemistry. As a spin-off of the Department of Pharmaceutical and Medicinal Chemistry of Saarland University ElexoPharm can revert to over 20 years of experience in design, synthesis and biological evaluation of new drugs.YEAR FOUNDED:
2005
5 articles about ElexoPharm GmbH
-
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement
1/31/2022
Exopharm Limited has signed a Master Collaborative Services Agreement with the Astellas Institute for Regenerative Medicine.
-
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines
12/22/2021
Exopharm Limited has been granted US patent US 11202805 for its LEAP™ exosome purification technology.
-
First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study
1/29/2020
Regenerative medicine company Exopharm Limited announces first dosing has occurred in the PLEXOVAL Phase I study using exosomes isolated from human platelets for wound healing, Exopharm’s first human clinical trial.
-
Exopharm Backs Regulatory Crackdown on Unapproved Exosome Products
12/19/2019
A leading developer of exosome therapies, Australia-based Exopharm Limited, supports the US Food & Drug Administration in highlighting the health dangers of unapproved products peddled by clinics that are openly flouting the rules.
-
Angion Biomedica Corp. Exclusively In-Licenses Aldosterone Synthase Inhibitors From ElexoPharm GmbH Complementing Its Ongoing Program In Chronic Kidney Disease
6/22/2017